Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Oncology

Issue 2/2007

Content (7 Articles)

Chronic Leukemia

Outline for Writing an Article for Current Treatment Options in Oncology: Splenic Lymphoma with Villous Lymphocytes

Xavier Troussard, Edouard Cornet

Chronic Leukemia

Splenic marginal zone lymphoma with and without villous lymphocytes

Estella Matutes

Chronic Leukemia

Current Treatment Options: Impact of Cytogenetics on the Course of Myelodysplasia

Naomi Galili, Jan Cerny, Azra Raza

Chronic Leukemia

Hairy Cell Leukemia

Rossella Riccioni, Sara Galimberti, Mario Petrini

Plasma Cell Dyscrasias

Initial Therapy of Multiple Myeloma in Patients who are Candidates for Stem Cell Transplantation

William Bensinger

Plasma Cell Dyscrasias

Treatment of Waldenstrom’s Macroglobulinemia

Meletios A. Dimopoulos, Athanasios Anagnostopoulos

Plasma cell

Lenalidomide in Myeloma

Seema Singhal, Jayesh Mehta

Feb 07
Issue: 1/2007
Jun 07
Issue: 3/2007

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits